Ignite Creation Date:
2025-12-25 @ 3:38 AM
Ignite Modification Date:
2026-01-11 @ 5:01 PM
Study NCT ID:
NCT03825302
Status:
WITHDRAWN
Last Update Posted:
2022-03-17
First Post:
2019-01-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Prostaglandin E2 as a Critical Mediator of Sex Disparities in Asthma
Sponsor:
Vanderbilt University Medical Center
Organization:
Study Overview
Official Title:
Prostaglandin E2 as a Critical Mediator of Sex Disparities in Asthma
Status:
WITHDRAWN
Status Verified Date:
2022-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
No funding available.
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study seeks to understand how biological sex influences airway hyperresponsiveness in adult asthma.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: